Bioinformatics firm Ariadne Genomics, Inc., US, has announced that drug manufacturer Pfizer, US, has purchased a multi-site licence for Ariadne's Pathway Studio Enterprise software. Pfizer will use the tool to assemble reference networks of biological interactions from internal and public data sources for interpretation of experimental results throughout its research facilities.
Pathway Studio Enterprise includes functionality to import and analyse microarray and proteomics data, and includes the Ariadne ResNet database, a collection of interaction data retrieved by MedScan technology from PubMed and open-text journals. Pfizer has additionally purchased a copy of Prolexys Human Interaction Database, a proprietary high-confidence source of human protein interactions built by Prolexys, Inc. using Y2H technology and repackaged for Pathway Studio.
Pathway Studio is used worldwide as a comprehensive solution for analysis and searching of pathways and molecular interaction information, according to the company. Ariadne offers desktop and enterprise editions of Pathway Studio which are supported by several commercial and publicly available molecular interaction databases including ResNet Mammalian and ResNet Plant. Pathway Studio is powered by MedScan Technology, which can be used to edit and enhance database content from the current literature and from experimental data.
More News in this Theme
